Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10119)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 21, 2016 (publication date) through Apr 15, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chen R, Lai LA, Brentnall TA, Pan S. Biomarkers for colitis-associated colorectal cancer. World J Gastroenterol 2016; 22(35): 7882-7891 [PMID: 27672285 DOI: 10.3748/wjg.v22.i35.7882] |
|---|---|
| URL: | https://www.wjgnet.com/2308-3840/full/v22/i35/7882.htm |
| Number | Citing Articles |
| 1 |
Fangqing Zhu, Sheng Li, Qiuping Gu, Ningsheng Xie, Yinxia Wu. APOL1 Induces Pyroptosis of Fibroblasts Through NLRP3/Caspase-1/GSDMD Signaling Pathway in Ulcerative Colitis. Journal of Inflammation Research 2023; : 6385 doi: 10.2147/JIR.S437875
|
| 2 |
Isabel Quintanilla, Gerhard Jung, Mireya Jimeno, Juan José Lozano, Julia Sidorova, Jordi Camps, Sabela Carballal, Luis Bujanda, Maria Isabel Vera, Enrique Quintero, Marta Carrillo-Palau, Miriam Cuatrecasas, Antoni Castells, Julià Panés, Elena Ricart, Leticia Moreira, Francesc Balaguer, Maria Pellisé. Differentially Deregulated MicroRNAs as Novel Biomarkers for Neoplastic Progression in Ulcerative Colitis. Clinical and Translational Gastroenterology 2022; 13(7): e00489 doi: 10.14309/ctg.0000000000000489
|
| 3 |
Hong-Yuan Tsai, Mary P. Bronner, Jordon K. March, John F. Valentine, Noah F. Shroyer, Lisa A. Lai, Teresa A. Brentnall, Sheng Pan, Ru Chen. Metabolic targeting of NRF2 potentiates the efficacy of the TRAP1 inhibitor G-TPP through reduction of ROS detoxification in colorectal cancer. Cancer Letters 2022; 549: 215915 doi: 10.1016/j.canlet.2022.215915
|
| 4 |
Weitao Hu, Taiyong Fang, Xiaoqing Chen. Identification of Differentially Expressed Genes and miRNAs for Ulcerative Colitis Using Bioinformatics Analysis. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.914384
|
| 5 |
Marie Hanaoka, Toshiaki Ishikawa, Megumi Ishiguro, Michiyo Tokura, Shinichi Yamauchi, Akifumi Kikuchi, Hiroyuki Uetake, Masamichi Yasuno, Tatsuyuki Kawano. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia. Journal of Gastroenterology 2018; 53(5): 631 doi: 10.1007/s00535-017-1387-1
|
| 6 |
Mehmet Yalchin, Ann-Marie Baker, Trevor A. Graham, Ailsa Hart. Predicting Colorectal Cancer Occurrence in IBD. Cancers 2021; 13(12): 2908 doi: 10.3390/cancers13122908
|
| 7 |
Stamatia Papoutsopoulou, Jack Satsangi, Barry J. Campbell, Chris S. Probert. Review article: impact of cigarette smoking on intestinal inflammation—direct and indirect mechanisms. Alimentary Pharmacology & Therapeutics 2020; 51(12): 1268 doi: 10.1111/apt.15774
|
| 8 |
Fukuichiro Orita, Toshiaki Ishikawa, Megumi Ishiguro, Satoshi Okazaki, Akifumi Kikuchi, Shinichi Yamauchi, Takatoshi Matsuyama, Masanori Tokunaga, Hiroyuki Uetake, Yusuke Kinugasa. PHLDA1 expression in ulcerative colitis: A potential role in the management of dysplasia. Molecular and Clinical Oncology 2021; 15(3) doi: 10.3892/mco.2021.2354
|
| 9 |
Pasuk Mahakkanukrauh, Apichat Sinthubua, Srijit Das. Methylated MicroRNA Biomarkers for Identifying Ulcerative Colitis–Associated Colorectal Cancers. Gastroenterology 2018; 154(6): 1852 doi: 10.1053/j.gastro.2017.12.048
|
| 10 |
Koyeli Girigoswami, Agnishwar Girigoswami. A Review on the Role of Nanosensors in Detecting Cellular miRNA Expression in Colorectal Cancer. Endocrine, Metabolic & Immune Disorders - Drug Targets 2021; 21(1): 12 doi: 10.2174/1871530320666200515115723
|
| 11 |
Wenwen Chen, Lin He, Lian Zhong, Jiayi Sun, Lilin Zhang, Daneng Wei, Chunjie Wu. Identification of Active Compounds and Mechanism of Huangtu Decoction for the Treatment of Ulcerative Colitis by Network Pharmacology Combined with Experimental Verification. Drug Design, Development and Therapy 2021; : 4125 doi: 10.2147/DDDT.S328333
|
| 12 |
Hitoshi Kameyama, Masayuki Nagahashi, Yoshifumi Shimada, Yosuke Tajima, Hiroshi Ichikawa, Masato Nakano, Jun Sakata, Takashi Kobayashi, Sumana Narayanan, Kazuaki Takabe, Toshifumi Wakai. Genomic characterization of colitis-associated colorectal cancer. World Journal of Surgical Oncology 2018; 16(1) doi: 10.1186/s12957-018-1428-0
|
| 13 |
Anne-Charlotte Heba, Simon Toupance, Djésia Arnone, Laurent Peyrin-Biroulet, Anthanase Benetos, Ndeye Coumba Ndiaye. Telomeres: New players in immune-mediated inflammatory diseases?. Journal of Autoimmunity 2021; 123: 102699 doi: 10.1016/j.jaut.2021.102699
|
| 14 |
Elen Farinelli de Campos Silva, Julio Pinheiro Baima, Jaqueline Ribeiro de Barros, Suzana Erico Tanni, Thomas Schreck, Rogerio Saad-Hossne, Ligia Yukie Sassaki. Risk factors for ulcerative colitis-associated colorectal cancer. Medicine 2020; 99(32): e21686 doi: 10.1097/MD.0000000000021686
|
| 15 |
Guo-Yan Sui, Feng Wang, Jin Lee, Yoon Seok Roh. Mitochondrial Control in Inflammatory Gastrointestinal Diseases. International Journal of Molecular Sciences 2022; 23(23): 14890 doi: 10.3390/ijms232314890
|
| 16 |
Carlos Augusto Real Martinez, José Aires Pereira, Julia Soto Rizzato, Gabriele Polezi, Roberto de Paula do Nascimento, Mario Roberto Marostica Junior. Natural Plant Products in Inflammatory Bowel Diseases. 2023; : 415 doi: 10.1016/B978-0-323-99111-7.00016-7
|
| 17 |
Yuan Feng, Yuan Zhang, Di Zhou, Gang Chen, Ning Li. MicroRNAs, intestinal inflammatory and tumor. Bioorganic & Medicinal Chemistry Letters 2019; 29(16): 2051 doi: 10.1016/j.bmcl.2019.06.013
|
| 18 |
Jing Zhou, Jialing Liu, Yangyang Gao, Liwei Shen, Sheng Li, Simin Chen. miRNA-Based Potential Biomarkers and New Molecular Insights in Ulcerative Colitis. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.707776
|
| 19 |
Hong Liu, Wenzhu Lu, Hongbo He, Jin Wu, Caiguo Zhang, Hanlin Gong, Chunmei Yang. Inflammation‐dependent overexpression of c‐Myc enhances CRL4DCAF4 E3 ligase activity and promotes ubiquitination of ST7 in colitis‐associated cancer. The Journal of Pathology 2019; 248(4): 464 doi: 10.1002/path.5273
|
| 20 |
Shun Tamaki, Hiromasa Imaishi. Inhibitory effects of type 2 diabetes serum components in P450 inhibition assays can potential diagnose asymptomatic diabetic mice. Drug Metabolism and Pharmacokinetics 2020; 35(6): 497 doi: 10.1016/j.dmpk.2020.07.003
|
| 21 |
Jaslin P. James, Lene Buhl Riis, Mikkel Malham, Estrid Høgdall, Ebbe Langholz, Boye S Nielsen. MicroRNA Biomarkers in IBD—Differential Diagnosis and Prediction of Colitis-Associated Cancer. International Journal of Molecular Sciences 2020; 21(21): 7893 doi: 10.3390/ijms21217893
|
| 22 |
Yao Li, Ren Guo, Chunyan Deng, Dai Li, Huiyun Wu. A Prussian blue nanoparticles-based fluorescent nanoprobe for monitoring microRNA-92a and microRNA-21. Analytical Sciences 2022; 38(3): 497 doi: 10.2116/analsci.20P455
|
| 23 |
Tomasz Mackiewicz, Aleksander Sowa, Jakub Fichna. Biomarkers for Early Detection of Colitis-associated Colorectal Cancer - Current Concepts, Future Trends. Current Drug Targets 2020; 22(1): 137 doi: 10.2174/1389450121666200220123844
|